| Literature DB >> 29133895 |
Yong Huang1, Qian Feng2, Kai Wang1, Xiaoli Xiong2, Shubing Zou3.
Abstract
The purpose of this study was to evaluate the safety and feasibility of laparoscopic common bile duct exploration (LCBDE) in patients with previous abdominal surgery (PAS). The outcomes were compared in 139 patients (103 upper and 36 lower abdominal surgeries) with PAS and 361 without PAS who underwent LCBDE. The operative time, hospital stay, rate of open conversion, postoperative complications, duct clearance, and blood loss were compared. Patients with PAS had longer operative times (P = 0.006), higher hospital costs (P = 0.043), and a higher incidence of wound complications (P = 0.011) than those without PAS. However, there were no statistically significant in the open conversion rate, blood loss, hospital stay, bile leakage, biliary strictures, residual stones, and mortality between patients with and without PAS (P > 0.05). Moreover, compared with those without PAS, patients with previous upper abdominal surgery (PUAS) had longer operative times (P = 0.005), higher hospital costs (P = 0.030), and a higher open conversion rate (P = 0.043), but patients with previous lower abdominal surgery (PLAS) had a higher incidence of wound complications (P = 0.022). LCBDE is considered safe and feasible for patients with PAS, including those with PUAS.Entities:
Mesh:
Year: 2017 PMID: 29133895 PMCID: PMC5684132 DOI: 10.1038/s41598-017-15782-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of patients with and without previous abdominal surgery.
| GroupA ( | GroupB ( |
| |
|---|---|---|---|
| Gender (M/F) | 144/183 | 53/68 | 0.989 |
| Age (years) | 56.6 ± 16.5 | 57.9 ± 14.8 | 0.045 |
| Primary closure/T tube | 235/90 | 81/40 | |
| CBD size (mm) | 12.9 ± 3.8 | 13.4 ± 4.6 | 0.238 |
| Laboratory data | |||
| WBC (109/L) | 10.6 ± 3.7 | 11.1 ± 3.9 | 0.258 |
| AST (U/L) | 54.3 (35.7,83.4) | 51.2 (36.7,81.4) | 0.788 |
| ALT (U/L) | 63.4 (39.5,108.5) | 58.5 (35.7,85.6) | 0.197 |
| GGT (U/L) | 194 (91,365) | 192 (90,346) | 0.831 |
| Blood loss (ml) | 25 (20,30) | 26 (22,36) | 0.297 |
| Operative time (min) | 177.1 ± 60.5 | 195.5 ± 64.6 |
|
| Hospital stay (days) | 15.0 ± 5.6 | 14.7 ± 5.0 | 0.636 |
| Hospital expenses (WanRMB) | 3.75 ± 1.23 | 4.04 ± 2.38 |
|
| Conversion | 34 | 18 | 0.246 |
| Postoperative complication | 31 | 16 | 0.251 |
| Biliary stricture | 2 | 2 | 0.296 |
| Wound complication | 4 | 7 |
|
| Bile leakage | 6 | 0 | 0.197 |
| Residual stones | 19 | 6 | 0.820 |
| Mortality | 0 | 1 | 0.270 |
GroupA, without previous abdominal surgery; GroupB, with previous abdominal surgery; WBC, blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase; WanRMB, ten thousand renminbi.
Types of previous abdominal operations.
| Incision | Surgical history |
|
|---|---|---|
| Upper abdominal | CBD exploration | 15 |
| Gastrectomy | 14 | |
| Splenectomy | 1 | |
| Hepatectomy | 3 | |
| Bowel resection | 6 | |
| Cholecystectomy | 47 | |
| Lower abdominal | Appendectomy | 11 |
| Hysterectomy | 6 | |
| Cesarotomy | 18 |
Characteristics of patients with previous upper and lower abdominal surgery.
| Upper ( |
| Lower ( |
| |
|---|---|---|---|---|
| Gender (M/F) | 44/42 | 0.218 | 9/26 |
|
| Age (years) | 59.8 ± 14.3 | 0.100 | 53.2 ± 15.0 | 0.236 |
| CBD size (mm) | 14.1 ± 4.8 |
| 11.8 ± 3.4 | 0.098 |
| Laboratory data | ||||
| WBC (109/L) | 11.0 ± 3.8 | 0.378 | 11.2 ± 4.2 | 0.378 |
| AST (U/L) | 49.3 (37.4,76.4) | 0.305 | 46.9 (37.4,76.4) | 0.305 |
| ALT (U/L) | 56.2 (35.7,82.3) | 0.585 | 65.5 (38.2,83.2) | 0.585 |
| GGT (U/L) | 187 (91.1,371.1) | 0.786 | 186 (89,358) | 0.786 |
| Blood loss (ml) | 26 (23,50) | 0.430 | 25 (20,43) | 0.430 |
| Operative time (min) | 194.8 ± 68.1 |
| 196.1 ± 55.3 | 0.075 |
| Hospital stay (days) | 14.7 ± 5.3 | 0.730 | 14.6 ± 4.5 | 0.697 |
| Hospital expenses (WanRMB) | 4.19 ± 2.75 |
| 3.67 ± 0.94 | 0.725 |
| Conversion | 17 |
| 1 | 0.348 |
| Postoperative complication | 11 | 0.366 | 4 | 0.762 |
| Biliary stricture | 1 | 0.505 | 0 | 1.000 |
| Wound complication | 4 | 0.062 | 3 |
|
| Bile leakage | 0 | 0.352 | 0 | 1.000 |
| Residual stones | 5 | 0.999 | 1 | 0.707 |
| Mortality | 1 | 0.208 | 0 | — |
1Statistically significant patients with previous upper abdominal surgery vs without previous abdominal surgery; 2Statistically significant patients with previous lower abdominal surgery vs without previous abdominal surgery; WBC, blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase. WanRMB, ten thousand renminbi.
Characteristics of primary closure patients.
| GroupA ( | GroupB ( |
| |
|---|---|---|---|
| Gender (M/F) | 101/135 | 29/28 | 0.372 |
| Age (years) | 56.5 ± 16.8 | 60.9 ± 13.3 | 0.064 |
| CBD size (mm) | 12.7 ± 3.7 | 14.1 ± 4.5 |
|
| Laboratory data | |||
| WBC (109/L) | 10.2 ± 3.6 | 10.8 ± 3.8 | 0.274 |
| AST (U/L) | 53.3 (35.5,84.0) | 51.6 (39.7,76.9) | 0.768 |
| ALT (U/L) | 61.8 (39.5,108.8) | 52.1 (35.7,76.5) | 0.147 |
| GGT (U/L) | 193 (81,370) | 188 (104,370) | 0.855 |
| Blood loss (ml) | 25 (20,30) | 30 (24,75) |
|
| Operative time (min) | 170.1 ± 58.5 | 175.9 ± 57.4 | 0.500 |
| Hospital stay (days) | 14.7 ± 4.9 | 14.7 ± 5.0 | 0.996 |
| Hospital expenses (WanRMB) | 3.64 ± 1.05 | 3.90 ± 1.42 | 0.117 |
| Postoperative complication | 31 | 6 | 0.566 |
| Biliary stricture | 1 | 1 | 0.356 |
| Wound complication | 2 | 2 | 0.176 |
| Bile leakage | 4 | 0 | 1.000 |
| Residual stones | 14 | 2 | 0.746 |
| Mortality | 0 | 1 | 0.197 |
GroupA, without previous abdominal surgery; GroupB, with previous abdominal surgery; WBC, blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase. WanRMB, ten thousand renminbi.
Characteristics and perioperative outcomes of T-tube patients.
| GroupA ( | GroupB ( |
| |
|---|---|---|---|
| Gender (M:F) | 43/48 | 15/14 | 0.974 |
| Age (years) | 56.9 ± 15.8 | 57.6 ± 16.3 | 0.845 |
| CBD size (mm) | 13.5 ± 3.8 | 13.9 ± 5.5 | 0.692 |
| Laboratory data | |||
| WBC (109/L) | 11.7 ± 3.9 | 11.5 ± 3.9 | 0.815 |
| AST (U/L) | 55.7 (36.0,82.6) | 47.6 (33.7,74.5) | 0.362 |
| ALT (U/L) | 66.1 (39.6,102.7) | 65.5 (37.5,83.2) | 0.395 |
| GGT (U/L) | 196 (115,350) | 198 (89,394) | 0.849 |
| Blood loss (ml) | 30 (23,35) | 25 (20,43) | 0.298 |
| Operative time (min) | 195.2 ± 62.1 | 233.9 ± 72.6 |
|
| Hospital stay (days) | 15.6 ± 7.0 | 14.8 ± 5.8 | 0.564 |
| Hospital expenses (WanRMB) | 4.03 ± 1.60 | 4.78 ± 4.36 | 0.175 |
| Postoperative complication | 11 | 8 |
|
| Biliary stricture | 1 | 0 | 1.000 |
| Wound complication | 3 | 5 |
|
| Bile leakage | 2 | 0 | 1.000 |
| Residual stones | 5 | 3 | 0.392 |
GroupA, without previous abdominal surgery; GroupB, with previous abdominal surgery; WBC, blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase. WanRMB, ten thousand renminbi.